Hidradenitis Suppurativa in Pediatrics: Management Challenges and Special Populations

The presentation discusses the challenges of diagnosing and managing Hidradenitis Suppurativa (HS) in pediatric patients, particularly focusing on special populations such as those with Trisomy 21 and autism spectrum disorder. It highlights that while HS is not common in children, a significant number present with symptoms during adolescence, often already manifesting scarring. The discussion includes specific clinical features and presentation patterns seen in pediatric HS, including the prevalence among African American females and early onset being more likely in males or those with a family history. Special considerations are given to children with Trisomy 21, who experience higher rates of HS due to immune system abnormalities, increased obesity risk, and observations of amyloid precursor protein overexpression affecting inflammation. Management strategies are complicated by communication barriers in this population as they can struggle to express discomfort or treatment side effects. The presentation emphasizes the need for careful monitoring and appropriate treatment adjustments, especially given the potential for paradoxical HS in patients receiving TNF-alpha inhibitors. The speaker calls for increased awareness among healthcare providers to better identify and treat pediatric HS at earlier stages to prevent lasting damage and improve quality of life, considering unique challenges faced by patients with developmental disabilities.